Recent articles by Valerie Tucker

Yamanaka receives Lasker Award for stem cell research

September 14, 2009
Shinya Yamanaka, MD, PhD, of the UCSF-affiliated Gladstone Institute of Cardiovascular Disease and Kyoto University, has won the 2009 Albert Lasker Basic Medical Research Award for his discovery of a method of reprogramming adult skin cells to become embryonic-like stem cells. Yamanaka, who is the L.K. Whittier Investigator in Stem Cell Biology at Gladstone and professor of anatomy at UCSF, is one of the youngest recipients of the award, which is one of the highest scientific honors bestowed in the United States.

Mayor Proclaims Gladstone Institutes Day in San Francisco

March 31, 2008
By Valerie Tucker San Francisco Mayor Gavin Newsom has proclaimed Tuesday, April 1, as Gladstone Institutes Day in San Francisco. The city is honoring the research organization for its 30 years of contributions to science, as well as its commitment to excellence in training future scientists.

Gladstone Ranked #1 in the Scientist's Survey of Best Places for Postdoctoral Fellows to Work

March 03, 2008
By Valerie Tucker San Francisco's J. David Gladstone Institutes is once again ranked as the best place for postdoctoral fellows to work in the United States. In the annual survey, published by The Scientist magazine, Gladstone received high marks for its strong infrastructure and networking opportunities, and was recognized for its consistently high rankings over the last 4 years.

Gladstone & UCSF Scientists Reactivate Immune Cell Production in HIV-Infected Adults

February 22, 2008
By Valerie Tucker Scientists at the Gladstone Institute of Virology and Immunology (GIVI) and the University of California, San Francisco (UCSF) have found that therapy can be used to stimulate the production of vital immune cells, called "T- cells," in adults with HIV infection.

Gilead Sciences and Gladstone to Collaborate on HIV Targets

January 10, 2008
By Valerie Tucker Gilead Sciences, Inc. and the Gladstone Institute of Virology and Immunology (GIVI) today, January 10, announced a multiyear research collaboration focusing on the HIV Vif protein. Vif promotes destruction of a potent host antiviral factor that is critical for the effective growth and spread of the virus in infected patients. Gilead will collaborate with the laboratory of GIVI Director Warner C. Greene, MD, PhD, in these studies.

Gladstone Scientists Cited in Top 50 Achievements for 2007

December 26, 2007
By Valerie Tucker Scientific American magazine has cited researchers at the Gladstone Institute of Cardiovascular Disease (GICD) and the University of California, Berkeley for one of the top 50 achievements in business, policy and research for the year 2007.

Acclaimed Stem Cell Scientist Joins Gladstone Institutes

August 22, 2007
The first scientist to report on a new method for "reprogramming" skin cells from mice into embryonic-like cells that can differentiate into other types of cells has joined the Gladstone Institute of Cardiovascular Disease.